nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—CYP1A2—Dacarbazine—muscle cancer	0.143	0.671	CbGbCtD
Frovatriptan—CYP1A2—Etoposide—muscle cancer	0.07	0.328	CbGbCtD
Frovatriptan—Myocardial infarction—Vincristine—muscle cancer	0.00434	0.00551	CcSEcCtD
Frovatriptan—Stomatitis—Vincristine—muscle cancer	0.00431	0.00548	CcSEcCtD
Frovatriptan—Hyperaesthesia—Doxorubicin—muscle cancer	0.00423	0.00538	CcSEcCtD
Frovatriptan—Flushing—Dactinomycin—muscle cancer	0.00413	0.00524	CcSEcCtD
Frovatriptan—Rigors—Doxorubicin—muscle cancer	0.00407	0.00517	CcSEcCtD
Frovatriptan—Dysphagia—Etoposide—muscle cancer	0.00402	0.00511	CcSEcCtD
Frovatriptan—Chills—Dactinomycin—muscle cancer	0.00399	0.00507	CcSEcCtD
Frovatriptan—Hypoaesthesia—Vincristine—muscle cancer	0.00395	0.00502	CcSEcCtD
Frovatriptan—Urinary tract disorder—Vincristine—muscle cancer	0.00392	0.00498	CcSEcCtD
Frovatriptan—Sweating increased—Etoposide—muscle cancer	0.00392	0.00497	CcSEcCtD
Frovatriptan—Urethral disorder—Vincristine—muscle cancer	0.00389	0.00495	CcSEcCtD
Frovatriptan—Cardiovascular disorder—Doxorubicin—muscle cancer	0.00378	0.00481	CcSEcCtD
Frovatriptan—Arthropathy—Doxorubicin—muscle cancer	0.00365	0.00464	CcSEcCtD
Frovatriptan—Hypocalcaemia—Doxorubicin—muscle cancer	0.00363	0.00461	CcSEcCtD
Frovatriptan—Thinking abnormal—Doxorubicin—muscle cancer	0.00363	0.00461	CcSEcCtD
Frovatriptan—Ill-defined disorder—Dactinomycin—muscle cancer	0.00359	0.00456	CcSEcCtD
Frovatriptan—Nocturia—Doxorubicin—muscle cancer	0.00358	0.00455	CcSEcCtD
Frovatriptan—Acute coronary syndrome—Etoposide—muscle cancer	0.00353	0.00449	CcSEcCtD
Frovatriptan—Myocardial infarction—Etoposide—muscle cancer	0.00351	0.00446	CcSEcCtD
Frovatriptan—Stomatitis—Etoposide—muscle cancer	0.00349	0.00444	CcSEcCtD
Frovatriptan—Malaise—Dactinomycin—muscle cancer	0.00349	0.00443	CcSEcCtD
Frovatriptan—Mental disorder—Vincristine—muscle cancer	0.00348	0.00442	CcSEcCtD
Frovatriptan—Urine output increased—Methotrexate—muscle cancer	0.00347	0.00441	CcSEcCtD
Frovatriptan—Bone pain—Doxorubicin—muscle cancer	0.00347	0.00441	CcSEcCtD
Frovatriptan—Gait disturbance—Doxorubicin—muscle cancer	0.0034	0.00433	CcSEcCtD
Frovatriptan—Back pain—Vincristine—muscle cancer	0.00334	0.00425	CcSEcCtD
Frovatriptan—Ventricular tachycardia—Doxorubicin—muscle cancer	0.00332	0.00422	CcSEcCtD
Frovatriptan—Hiccups—Doxorubicin—muscle cancer	0.00332	0.00422	CcSEcCtD
Frovatriptan—Myalgia—Dactinomycin—muscle cancer	0.00329	0.00419	CcSEcCtD
Frovatriptan—Eructation—Doxorubicin—muscle cancer	0.00326	0.00415	CcSEcCtD
Frovatriptan—Discomfort—Dactinomycin—muscle cancer	0.00325	0.00414	CcSEcCtD
Frovatriptan—Salivary hypersecretion—Doxorubicin—muscle cancer	0.00323	0.0041	CcSEcCtD
Frovatriptan—Hypoaesthesia—Etoposide—muscle cancer	0.0032	0.00407	CcSEcCtD
Frovatriptan—Urinary tract disorder—Etoposide—muscle cancer	0.00318	0.00404	CcSEcCtD
Frovatriptan—Agitation—Vincristine—muscle cancer	0.00318	0.00404	CcSEcCtD
Frovatriptan—Polyuria—Methotrexate—muscle cancer	0.00317	0.00403	CcSEcCtD
Frovatriptan—Urethral disorder—Etoposide—muscle cancer	0.00315	0.00401	CcSEcCtD
Frovatriptan—Vertigo—Vincristine—muscle cancer	0.00311	0.00395	CcSEcCtD
Frovatriptan—Cramps of lower extremities—Doxorubicin—muscle cancer	0.00305	0.00388	CcSEcCtD
Frovatriptan—Anorexia—Dactinomycin—muscle cancer	0.00301	0.00382	CcSEcCtD
Frovatriptan—Convulsion—Vincristine—muscle cancer	0.003	0.00381	CcSEcCtD
Frovatriptan—Flushing—Etoposide—muscle cancer	0.00299	0.00379	CcSEcCtD
Frovatriptan—Myalgia—Vincristine—muscle cancer	0.00294	0.00374	CcSEcCtD
Frovatriptan—Hypertonia—Doxorubicin—muscle cancer	0.00291	0.0037	CcSEcCtD
Frovatriptan—Abnormal vision—Doxorubicin—muscle cancer	0.0029	0.00368	CcSEcCtD
Frovatriptan—Chills—Etoposide—muscle cancer	0.00289	0.00367	CcSEcCtD
Frovatriptan—Mental disability—Doxorubicin—muscle cancer	0.00288	0.00366	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00288	0.00366	CcSEcCtD
Frovatriptan—Anaphylactic shock—Vincristine—muscle cancer	0.00282	0.00359	CcSEcCtD
Frovatriptan—Osteoarthritis—Methotrexate—muscle cancer	0.00279	0.00354	CcSEcCtD
Frovatriptan—Decreased appetite—Dactinomycin—muscle cancer	0.00275	0.00349	CcSEcCtD
Frovatriptan—Dysgeusia—Etoposide—muscle cancer	0.00274	0.00348	CcSEcCtD
Frovatriptan—Hyperhidrosis—Vincristine—muscle cancer	0.00273	0.00347	CcSEcCtD
Frovatriptan—Fatigue—Dactinomycin—muscle cancer	0.00272	0.00346	CcSEcCtD
Frovatriptan—Back pain—Etoposide—muscle cancer	0.00271	0.00344	CcSEcCtD
Frovatriptan—Pain—Dactinomycin—muscle cancer	0.0027	0.00343	CcSEcCtD
Frovatriptan—Vascular purpura—Doxorubicin—muscle cancer	0.0027	0.00343	CcSEcCtD
Frovatriptan—Muscle spasms—Etoposide—muscle cancer	0.00269	0.00342	CcSEcCtD
Frovatriptan—Anorexia—Vincristine—muscle cancer	0.00269	0.00342	CcSEcCtD
Frovatriptan—Eye pain—Doxorubicin—muscle cancer	0.00267	0.00339	CcSEcCtD
Frovatriptan—Mood swings—Methotrexate—muscle cancer	0.00264	0.00335	CcSEcCtD
Frovatriptan—Ataxia—Methotrexate—muscle cancer	0.00262	0.00333	CcSEcCtD
Frovatriptan—Feeling abnormal—Dactinomycin—muscle cancer	0.0026	0.00331	CcSEcCtD
Frovatriptan—Ill-defined disorder—Etoposide—muscle cancer	0.0026	0.0033	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00258	0.00328	CcSEcCtD
Frovatriptan—Hot flush—Doxorubicin—muscle cancer	0.00258	0.00328	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00257	0.00327	CcSEcCtD
Frovatriptan—Menopausal symptoms—Doxorubicin—muscle cancer	0.00256	0.00325	CcSEcCtD
Frovatriptan—Insomnia—Vincristine—muscle cancer	0.00255	0.00324	CcSEcCtD
Frovatriptan—Paraesthesia—Vincristine—muscle cancer	0.00253	0.00322	CcSEcCtD
Frovatriptan—Malaise—Etoposide—muscle cancer	0.00253	0.00321	CcSEcCtD
Frovatriptan—Dermatitis bullous—Doxorubicin—muscle cancer	0.00252	0.00321	CcSEcCtD
Frovatriptan—Vertigo—Etoposide—muscle cancer	0.00252	0.0032	CcSEcCtD
Frovatriptan—Purpura—Doxorubicin—muscle cancer	0.0025	0.00318	CcSEcCtD
Frovatriptan—Body temperature increased—Dactinomycin—muscle cancer	0.0025	0.00317	CcSEcCtD
Frovatriptan—Abdominal pain—Dactinomycin—muscle cancer	0.0025	0.00317	CcSEcCtD
Frovatriptan—Hypoglycaemia—Doxorubicin—muscle cancer	0.00247	0.00314	CcSEcCtD
Frovatriptan—Loss of consciousness—Etoposide—muscle cancer	0.00246	0.00313	CcSEcCtD
Frovatriptan—Decreased appetite—Vincristine—muscle cancer	0.00245	0.00312	CcSEcCtD
Frovatriptan—Fatigue—Vincristine—muscle cancer	0.00243	0.00309	CcSEcCtD
Frovatriptan—Convulsion—Etoposide—muscle cancer	0.00243	0.00308	CcSEcCtD
Frovatriptan—Pain—Vincristine—muscle cancer	0.00241	0.00307	CcSEcCtD
Frovatriptan—Constipation—Vincristine—muscle cancer	0.00241	0.00307	CcSEcCtD
Frovatriptan—Pain in extremity—Doxorubicin—muscle cancer	0.00241	0.00306	CcSEcCtD
Frovatriptan—Osteoarthritis—Doxorubicin—muscle cancer	0.00241	0.00306	CcSEcCtD
Frovatriptan—Chest pain—Etoposide—muscle cancer	0.00238	0.00303	CcSEcCtD
Frovatriptan—Affect lability—Doxorubicin—muscle cancer	0.00237	0.00302	CcSEcCtD
Frovatriptan—Migraine—Doxorubicin—muscle cancer	0.00237	0.00302	CcSEcCtD
Frovatriptan—Discomfort—Etoposide—muscle cancer	0.00236	0.00299	CcSEcCtD
Frovatriptan—Hypersensitivity—Dactinomycin—muscle cancer	0.00233	0.00296	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Vincristine—muscle cancer	0.00231	0.00293	CcSEcCtD
Frovatriptan—Confusional state—Etoposide—muscle cancer	0.0023	0.00293	CcSEcCtD
Frovatriptan—Anaphylactic shock—Etoposide—muscle cancer	0.00229	0.0029	CcSEcCtD
Frovatriptan—Mood swings—Doxorubicin—muscle cancer	0.00228	0.0029	CcSEcCtD
Frovatriptan—Ataxia—Doxorubicin—muscle cancer	0.00227	0.00288	CcSEcCtD
Frovatriptan—Asthenia—Dactinomycin—muscle cancer	0.00227	0.00288	CcSEcCtD
Frovatriptan—Dehydration—Doxorubicin—muscle cancer	0.00224	0.00285	CcSEcCtD
Frovatriptan—Tachycardia—Etoposide—muscle cancer	0.00223	0.00283	CcSEcCtD
Frovatriptan—Body temperature increased—Vincristine—muscle cancer	0.00223	0.00283	CcSEcCtD
Frovatriptan—Abdominal pain—Vincristine—muscle cancer	0.00223	0.00283	CcSEcCtD
Frovatriptan—Hyperhidrosis—Etoposide—muscle cancer	0.00221	0.00281	CcSEcCtD
Frovatriptan—Anorexia—Etoposide—muscle cancer	0.00218	0.00277	CcSEcCtD
Frovatriptan—Diarrhoea—Dactinomycin—muscle cancer	0.00216	0.00275	CcSEcCtD
Frovatriptan—Depression—Methotrexate—muscle cancer	0.00214	0.00272	CcSEcCtD
Frovatriptan—Muscular weakness—Doxorubicin—muscle cancer	0.00213	0.0027	CcSEcCtD
Frovatriptan—Stomatitis—Methotrexate—muscle cancer	0.00209	0.00266	CcSEcCtD
Frovatriptan—Conjunctivitis—Methotrexate—muscle cancer	0.00209	0.00265	CcSEcCtD
Frovatriptan—Dysphagia—Doxorubicin—muscle cancer	0.00208	0.00265	CcSEcCtD
Frovatriptan—Hypersensitivity—Vincristine—muscle cancer	0.00208	0.00264	CcSEcCtD
Frovatriptan—Paraesthesia—Etoposide—muscle cancer	0.00205	0.00261	CcSEcCtD
Frovatriptan—Dyspnoea—Etoposide—muscle cancer	0.00204	0.00259	CcSEcCtD
Frovatriptan—Somnolence—Etoposide—muscle cancer	0.00203	0.00258	CcSEcCtD
Frovatriptan—Epistaxis—Methotrexate—muscle cancer	0.00202	0.00257	CcSEcCtD
Frovatriptan—Asthenia—Vincristine—muscle cancer	0.00202	0.00257	CcSEcCtD
Frovatriptan—Vomiting—Dactinomycin—muscle cancer	0.00201	0.00255	CcSEcCtD
Frovatriptan—Decreased appetite—Etoposide—muscle cancer	0.00199	0.00252	CcSEcCtD
Frovatriptan—Fatigue—Etoposide—muscle cancer	0.00197	0.0025	CcSEcCtD
Frovatriptan—Constipation—Etoposide—muscle cancer	0.00195	0.00248	CcSEcCtD
Frovatriptan—Pain—Etoposide—muscle cancer	0.00195	0.00248	CcSEcCtD
Frovatriptan—Haemoglobin—Methotrexate—muscle cancer	0.00194	0.00246	CcSEcCtD
Frovatriptan—Diarrhoea—Vincristine—muscle cancer	0.00193	0.00245	CcSEcCtD
Frovatriptan—Haemorrhage—Methotrexate—muscle cancer	0.00193	0.00245	CcSEcCtD
Frovatriptan—Pollakiuria—Doxorubicin—muscle cancer	0.00193	0.00245	CcSEcCtD
Frovatriptan—Pharyngitis—Methotrexate—muscle cancer	0.00191	0.00243	CcSEcCtD
Frovatriptan—Urinary tract disorder—Methotrexate—muscle cancer	0.0019	0.00242	CcSEcCtD
Frovatriptan—Urethral disorder—Methotrexate—muscle cancer	0.00189	0.0024	CcSEcCtD
Frovatriptan—Feeling abnormal—Etoposide—muscle cancer	0.00188	0.00239	CcSEcCtD
Frovatriptan—Nausea—Dactinomycin—muscle cancer	0.00188	0.00238	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Etoposide—muscle cancer	0.00187	0.00237	CcSEcCtD
Frovatriptan—Dizziness—Vincristine—muscle cancer	0.00187	0.00237	CcSEcCtD
Frovatriptan—Visual impairment—Methotrexate—muscle cancer	0.00186	0.00236	CcSEcCtD
Frovatriptan—Stomatitis—Doxorubicin—muscle cancer	0.00181	0.0023	CcSEcCtD
Frovatriptan—Abdominal pain—Etoposide—muscle cancer	0.00181	0.0023	CcSEcCtD
Frovatriptan—Body temperature increased—Etoposide—muscle cancer	0.00181	0.0023	CcSEcCtD
Frovatriptan—Conjunctivitis—Doxorubicin—muscle cancer	0.00181	0.0023	CcSEcCtD
Frovatriptan—Tinnitus—Methotrexate—muscle cancer	0.0018	0.00228	CcSEcCtD
Frovatriptan—Vomiting—Vincristine—muscle cancer	0.00179	0.00228	CcSEcCtD
Frovatriptan—Headache—Vincristine—muscle cancer	0.00177	0.00225	CcSEcCtD
Frovatriptan—Epistaxis—Doxorubicin—muscle cancer	0.00175	0.00223	CcSEcCtD
Frovatriptan—Sinusitis—Doxorubicin—muscle cancer	0.00174	0.00222	CcSEcCtD
Frovatriptan—Chills—Methotrexate—muscle cancer	0.00173	0.0022	CcSEcCtD
Frovatriptan—Bradycardia—Doxorubicin—muscle cancer	0.0017	0.00216	CcSEcCtD
Frovatriptan—Mental disorder—Methotrexate—muscle cancer	0.00169	0.00215	CcSEcCtD
Frovatriptan—Hypersensitivity—Etoposide—muscle cancer	0.00168	0.00214	CcSEcCtD
Frovatriptan—Malnutrition—Methotrexate—muscle cancer	0.00168	0.00213	CcSEcCtD
Frovatriptan—Haemoglobin—Doxorubicin—muscle cancer	0.00168	0.00213	CcSEcCtD
Frovatriptan—Nausea—Vincristine—muscle cancer	0.00168	0.00213	CcSEcCtD
Frovatriptan—Rhinitis—Doxorubicin—muscle cancer	0.00167	0.00213	CcSEcCtD
Frovatriptan—Haemorrhage—Doxorubicin—muscle cancer	0.00167	0.00212	CcSEcCtD
Frovatriptan—Hypoaesthesia—Doxorubicin—muscle cancer	0.00166	0.00211	CcSEcCtD
Frovatriptan—Pharyngitis—Doxorubicin—muscle cancer	0.00166	0.0021	CcSEcCtD
Frovatriptan—Urinary tract disorder—Doxorubicin—muscle cancer	0.00165	0.00209	CcSEcCtD
Frovatriptan—Dysgeusia—Methotrexate—muscle cancer	0.00164	0.00209	CcSEcCtD
Frovatriptan—Asthenia—Etoposide—muscle cancer	0.00164	0.00208	CcSEcCtD
Frovatriptan—Urethral disorder—Doxorubicin—muscle cancer	0.00164	0.00208	CcSEcCtD
Frovatriptan—Back pain—Methotrexate—muscle cancer	0.00162	0.00206	CcSEcCtD
Frovatriptan—Pruritus—Etoposide—muscle cancer	0.00162	0.00205	CcSEcCtD
Frovatriptan—Visual impairment—Doxorubicin—muscle cancer	0.00161	0.00204	CcSEcCtD
Frovatriptan—Diarrhoea—Etoposide—muscle cancer	0.00156	0.00199	CcSEcCtD
Frovatriptan—Ill-defined disorder—Methotrexate—muscle cancer	0.00156	0.00198	CcSEcCtD
Frovatriptan—Tinnitus—Doxorubicin—muscle cancer	0.00156	0.00198	CcSEcCtD
Frovatriptan—Flushing—Doxorubicin—muscle cancer	0.00155	0.00197	CcSEcCtD
Frovatriptan—Malaise—Methotrexate—muscle cancer	0.00151	0.00192	CcSEcCtD
Frovatriptan—Dizziness—Etoposide—muscle cancer	0.00151	0.00192	CcSEcCtD
Frovatriptan—Vertigo—Methotrexate—muscle cancer	0.00151	0.00191	CcSEcCtD
Frovatriptan—Chills—Doxorubicin—muscle cancer	0.0015	0.0019	CcSEcCtD
Frovatriptan—Arrhythmia—Doxorubicin—muscle cancer	0.00149	0.00189	CcSEcCtD
Frovatriptan—Mental disorder—Doxorubicin—muscle cancer	0.00146	0.00186	CcSEcCtD
Frovatriptan—Convulsion—Methotrexate—muscle cancer	0.00145	0.00185	CcSEcCtD
Frovatriptan—Vomiting—Etoposide—muscle cancer	0.00145	0.00185	CcSEcCtD
Frovatriptan—Malnutrition—Doxorubicin—muscle cancer	0.00145	0.00185	CcSEcCtD
Frovatriptan—Headache—Etoposide—muscle cancer	0.00143	0.00182	CcSEcCtD
Frovatriptan—Flatulence—Doxorubicin—muscle cancer	0.00143	0.00182	CcSEcCtD
Frovatriptan—Chest pain—Methotrexate—muscle cancer	0.00143	0.00181	CcSEcCtD
Frovatriptan—Myalgia—Methotrexate—muscle cancer	0.00143	0.00181	CcSEcCtD
Frovatriptan—Arthralgia—Methotrexate—muscle cancer	0.00143	0.00181	CcSEcCtD
Frovatriptan—Tension—Doxorubicin—muscle cancer	0.00143	0.00181	CcSEcCtD
Frovatriptan—Dysgeusia—Doxorubicin—muscle cancer	0.00142	0.00181	CcSEcCtD
Frovatriptan—Discomfort—Methotrexate—muscle cancer	0.00141	0.00179	CcSEcCtD
Frovatriptan—Nervousness—Doxorubicin—muscle cancer	0.00141	0.00179	CcSEcCtD
Frovatriptan—Back pain—Doxorubicin—muscle cancer	0.00141	0.00179	CcSEcCtD
Frovatriptan—Muscle spasms—Doxorubicin—muscle cancer	0.0014	0.00177	CcSEcCtD
Frovatriptan—Confusional state—Methotrexate—muscle cancer	0.00138	0.00175	CcSEcCtD
Frovatriptan—Anaphylactic shock—Methotrexate—muscle cancer	0.00137	0.00174	CcSEcCtD
Frovatriptan—Nausea—Etoposide—muscle cancer	0.00136	0.00173	CcSEcCtD
Frovatriptan—Ill-defined disorder—Doxorubicin—muscle cancer	0.00135	0.00171	CcSEcCtD
Frovatriptan—Agitation—Doxorubicin—muscle cancer	0.00133	0.0017	CcSEcCtD
Frovatriptan—Hyperhidrosis—Methotrexate—muscle cancer	0.00132	0.00168	CcSEcCtD
Frovatriptan—Malaise—Doxorubicin—muscle cancer	0.00131	0.00166	CcSEcCtD
Frovatriptan—Vertigo—Doxorubicin—muscle cancer	0.0013	0.00166	CcSEcCtD
Frovatriptan—Anorexia—Methotrexate—muscle cancer	0.0013	0.00166	CcSEcCtD
Frovatriptan—Syncope—Doxorubicin—muscle cancer	0.0013	0.00166	CcSEcCtD
Frovatriptan—Palpitations—Doxorubicin—muscle cancer	0.00128	0.00163	CcSEcCtD
Frovatriptan—Loss of consciousness—Doxorubicin—muscle cancer	0.00128	0.00162	CcSEcCtD
Frovatriptan—Convulsion—Doxorubicin—muscle cancer	0.00126	0.0016	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00125	0.00158	CcSEcCtD
Frovatriptan—Insomnia—Methotrexate—muscle cancer	0.00124	0.00157	CcSEcCtD
Frovatriptan—Myalgia—Doxorubicin—muscle cancer	0.00124	0.00157	CcSEcCtD
Frovatriptan—Chest pain—Doxorubicin—muscle cancer	0.00124	0.00157	CcSEcCtD
Frovatriptan—Arthralgia—Doxorubicin—muscle cancer	0.00124	0.00157	CcSEcCtD
Frovatriptan—Anxiety—Doxorubicin—muscle cancer	0.00123	0.00157	CcSEcCtD
Frovatriptan—Paraesthesia—Methotrexate—muscle cancer	0.00123	0.00156	CcSEcCtD
Frovatriptan—Discomfort—Doxorubicin—muscle cancer	0.00122	0.00155	CcSEcCtD
Frovatriptan—Dyspnoea—Methotrexate—muscle cancer	0.00122	0.00155	CcSEcCtD
Frovatriptan—Somnolence—Methotrexate—muscle cancer	0.00122	0.00155	CcSEcCtD
Frovatriptan—Dry mouth—Doxorubicin—muscle cancer	0.00121	0.00154	CcSEcCtD
Frovatriptan—Dyspepsia—Methotrexate—muscle cancer	0.00121	0.00153	CcSEcCtD
Frovatriptan—Confusional state—Doxorubicin—muscle cancer	0.0012	0.00152	CcSEcCtD
Frovatriptan—Decreased appetite—Methotrexate—muscle cancer	0.00119	0.00151	CcSEcCtD
Frovatriptan—Anaphylactic shock—Doxorubicin—muscle cancer	0.00119	0.00151	CcSEcCtD
Frovatriptan—Fatigue—Methotrexate—muscle cancer	0.00118	0.0015	CcSEcCtD
Frovatriptan—Pain—Methotrexate—muscle cancer	0.00117	0.00149	CcSEcCtD
Frovatriptan—Shock—Doxorubicin—muscle cancer	0.00117	0.00148	CcSEcCtD
Frovatriptan—Tachycardia—Doxorubicin—muscle cancer	0.00116	0.00147	CcSEcCtD
Frovatriptan—Hyperhidrosis—Doxorubicin—muscle cancer	0.00115	0.00146	CcSEcCtD
Frovatriptan—Anorexia—Doxorubicin—muscle cancer	0.00113	0.00144	CcSEcCtD
Frovatriptan—Feeling abnormal—Methotrexate—muscle cancer	0.00113	0.00143	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Methotrexate—muscle cancer	0.00112	0.00142	CcSEcCtD
Frovatriptan—Abdominal pain—Methotrexate—muscle cancer	0.00108	0.00138	CcSEcCtD
Frovatriptan—Body temperature increased—Methotrexate—muscle cancer	0.00108	0.00138	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00108	0.00137	CcSEcCtD
Frovatriptan—Insomnia—Doxorubicin—muscle cancer	0.00107	0.00136	CcSEcCtD
Frovatriptan—Paraesthesia—Doxorubicin—muscle cancer	0.00106	0.00135	CcSEcCtD
Frovatriptan—Dyspnoea—Doxorubicin—muscle cancer	0.00106	0.00134	CcSEcCtD
Frovatriptan—Somnolence—Doxorubicin—muscle cancer	0.00105	0.00134	CcSEcCtD
Frovatriptan—Dyspepsia—Doxorubicin—muscle cancer	0.00104	0.00133	CcSEcCtD
Frovatriptan—Decreased appetite—Doxorubicin—muscle cancer	0.00103	0.00131	CcSEcCtD
Frovatriptan—Fatigue—Doxorubicin—muscle cancer	0.00102	0.0013	CcSEcCtD
Frovatriptan—Pain—Doxorubicin—muscle cancer	0.00101	0.00129	CcSEcCtD
Frovatriptan—Constipation—Doxorubicin—muscle cancer	0.00101	0.00129	CcSEcCtD
Frovatriptan—Hypersensitivity—Methotrexate—muscle cancer	0.00101	0.00128	CcSEcCtD
Frovatriptan—Asthenia—Methotrexate—muscle cancer	0.000982	0.00125	CcSEcCtD
Frovatriptan—Feeling abnormal—Doxorubicin—muscle cancer	0.000977	0.00124	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000969	0.00123	CcSEcCtD
Frovatriptan—Pruritus—Methotrexate—muscle cancer	0.000969	0.00123	CcSEcCtD
Frovatriptan—Abdominal pain—Doxorubicin—muscle cancer	0.000937	0.00119	CcSEcCtD
Frovatriptan—Body temperature increased—Doxorubicin—muscle cancer	0.000937	0.00119	CcSEcCtD
Frovatriptan—Diarrhoea—Methotrexate—muscle cancer	0.000937	0.00119	CcSEcCtD
Frovatriptan—Dizziness—Methotrexate—muscle cancer	0.000905	0.00115	CcSEcCtD
Frovatriptan—Hypersensitivity—Doxorubicin—muscle cancer	0.000873	0.00111	CcSEcCtD
Frovatriptan—Vomiting—Methotrexate—muscle cancer	0.00087	0.00111	CcSEcCtD
Frovatriptan—Headache—Methotrexate—muscle cancer	0.000858	0.00109	CcSEcCtD
Frovatriptan—Asthenia—Doxorubicin—muscle cancer	0.000851	0.00108	CcSEcCtD
Frovatriptan—Pruritus—Doxorubicin—muscle cancer	0.000839	0.00107	CcSEcCtD
Frovatriptan—Nausea—Methotrexate—muscle cancer	0.000813	0.00103	CcSEcCtD
Frovatriptan—Diarrhoea—Doxorubicin—muscle cancer	0.000811	0.00103	CcSEcCtD
Frovatriptan—Dizziness—Doxorubicin—muscle cancer	0.000784	0.000996	CcSEcCtD
Frovatriptan—Vomiting—Doxorubicin—muscle cancer	0.000754	0.000958	CcSEcCtD
Frovatriptan—Headache—Doxorubicin—muscle cancer	0.000743	0.000944	CcSEcCtD
Frovatriptan—Nausea—Doxorubicin—muscle cancer	0.000704	0.000895	CcSEcCtD
